James MK - Search Results

1

Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs.

Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. Hoke JF, et al. Among authors: james mk. J Pharmacol Exp Ther. 1997 Apr;281(1):226-32. J Pharmacol Exp Ther. 1997. PMID: 9103501

2

Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide.

Hoffman WE, Cunningham F, James MK, Baughman VL, Albrecht RF. Hoffman WE, et al. Among authors: james mk. Anesthesiology. 1993 Jul;79(1):107-13; discussion 26A. doi: 10.1097/00000542-199307000-00016. Anesthesiology. 1993. PMID: 8342798

3

Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.

James MK, Vuong A, Grizzle MK, Schuster SV, Shaffer JE. James MK, et al. J Pharmacol Exp Ther. 1992 Oct;263(1):84-91. J Pharmacol Exp Ther. 1992. PMID: 1403806

4

Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.

Bramson HN, Hermann D, Batchelor KW, Lee FW, James MK, Frye SV. Bramson HN, et al. Among authors: james mk. J Pharmacol Exp Ther. 1997 Sep;282(3):1496-502. J Pharmacol Exp Ther. 1997. PMID: 9316864

5

Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.

James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ. James MK, et al. J Pharmacol Exp Ther. 1991 Nov;259(2):712-8. J Pharmacol Exp Ther. 1991. PMID: 1658308

6

Analysis of putative alpha-1s adrenoceptor agonism by Sgd 101/75 in the rat anococcygeus muscle.

James MK, Leighton HJ. James MK, et al. J Pharmacol Exp Ther. 1987 Sep;242(3):772-6. J Pharmacol Exp Ther. 1987. PMID: 2888872

7

A new method for estimation of agonist dissociation constants (KA): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation.

James MK, Morgan PH, Leighton HJ. James MK, et al. J Pharmacol Exp Ther. 1989 Apr;249(1):61-9. J Pharmacol Exp Ther. 1989. PMID: 2540322

8

A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.

Lutz MW, Morgan PH, James MK, Feldman PL, Brackeen MF, Lahey AP, James SV, Bilotta JM, Pressley JC. Lutz MW, et al. Among authors: james sv, james mk. J Pharmacol Exp Ther. 1994 Nov;271(2):795-803. J Pharmacol Exp Ther. 1994. PMID: 7965798

9

Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics.

Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster SV, Lahey AP, Lutz MW, Johnson MR, Leighton HJ. Feldman PL, et al. Among authors: james mk. J Med Chem. 1991 Jul;34(7):2202-8. doi: 10.1021/jm00111a041. J Med Chem. 1991. PMID: 2066993

10

Naloxazone treatment in the guinea pig ileum in vitro reveals second functional opioid receptor site.

James MK, Leighton HJ. James MK, et al. J Pharmacol Exp Ther. 1987 Jan;240(1):138-44. J Pharmacol Exp Ther. 1987. PMID: 3027301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters